Drug recall · May 29, 2024
niCARdipine Hydrochloride Injection recall
Why: Lack of Assurance of Sterility.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 x 10 mL Single Dose Vials, Rx Only, For Intravenous Use Only, Mfd for: Civica, Inc., Lehi, UT 84043; Mfd by: American Regent, Inc., New Albany, OH 43054. NDC 72572-470-10
- Lots / codes
Lot #: 23087N0C0, Exp. Date 11/2024
- Quantity
- 4,136 cartons (10 vials in each carton)
- Company
- American Regent, Inc., New Albany, OH
- Distribution
- UT only
- Initiated
- May 14, 2024 · Voluntary: Firm initiated
- Classified
- May 21, 2024
- Reported
- May 29, 2024
- Ended
- December 23, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Nicardipine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.